Patenting Antibodies: The epitope claim is dead, long live the epitope claim
http://ipkitten.blogspot.com/2021/11/patenting-antibodies-epitope-claim-is.html Antibodies may be defined in a patent claim by their amino acid sequence or by the sequence of the target (epitope) to which the antibody binds. Historically, epitope claims were relatively common in the field of antibody patents, as they represented a way of broadly protecting any antibody that... Continue reading